BRTX-100

BioRestorative Therapies · Phase 2 active Biologic

At a glance

Generic name	BRTX-100
Sponsor	BioRestorative Therapies
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BRTX-100 CI brief — competitive landscape report
BRTX-100 updates RSS · CI watch RSS
BioRestorative Therapies portfolio CI